Description
HER2/neu (869-877) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HER2/neu (869-877) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
| Purity | ≥95% |
|---|---|
| Formula | C49H75N9O20 |
| Formula Wt. | 1110.19 |
| Synonym | ErbB2, EGFR2 |
| Solubility | Soluble in water. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012;2012:743193. PMID: 23320171.
Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist. 2009 Nov;14(11):1061-9. PMID: 19887469.
Fermentation impurity
Triterpene sapogenin found in species of Panax;...
Camptothecin derivative; topoisomerase I inhibi...
STING agonist
Third generation macrocyclic ALK inhibitor.
Selective inhibitor of LRRK2.
EGFR inhibitor.
ACE inhibitor.
Ansamycin; bacterial DNA-dependent RNA polymera...
Macrolide originally produced by Streptomyces; ...
Endogenous steroid hormone, estriol precursor; ...
BK/SK, Kv1, Kv3, TASK-2 K+ channel blocker, vol...
RyR agonist, SIRT, telomerase, P2Y, GPCR inhibi...
ACE inhibitor.
α7 and β4 nAChR agonist, α4β2 and α6β2 nA...
CDK9 inhibitor.
PAK4 inhibitor.
β2-adrenergic agonist.
Tretraeptide, binds cell surface integrins.
Macrolide; protein translation inhibitor, mamma...